Wednesday, July 8, 2026

Intelligence · Clinical Development

Pipeline search results

Programs matching “healthy” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.

Matching programs 1,124
Total indexed 20,548
Sponsors 1,769

Quick answer

Showing 1,124 pipeline programs matching "healthy" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.

Refine search

1,124 results for “healthy” Back to intelligence hub

Search results

Page 10 of 47
  1. Anastrozole (Teva Pharmaceuticals USA)

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  2. Anplag

    United Therapeutics Europe Ltd

    Healthy

    phase 1 small molecule completed

    1 trial
  3. Anti CS6 BSIgG product (Lot PD1601105CS)

    United Therapeutics Europe Ltd

    Healthy Volunteer

    phase 1 mab completed

    1 trial
  4. Anti-human CCL24 monoclonal antibody (CM-101)

    Chemomab Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  5. Aramchol

    Galmed Pharmaceuticals

    Healthy

    phase 1 small molecule active

    4 trials
  6. Aramchol

    Galmed Pharmaceuticals

    Healthy Volunteers

    phase 1 small molecule completed

    2 trials
  7. Aramchol meglumine

    Galmed Pharmaceuticals

    Healthy

    phase 1 small molecule active

    1 trial
  8. Arbaclofen Placarbil SR

    Indivior Pty Ltd

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  9. Aricept 5mg Tablet

    Dong Wang

    Healthy

    phase 1 small molecule active

    1 trial
  10. Aspirin

    Regeneron UK Limited

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  11. Ataluren

    PTC THERAPEUTICS, INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  12. Atorvastatin

    Madrigal Pharmaceuticals EU Limited

    Healthy

    phase 1 small molecule completed

    1 trial
  13. Atorvastatin

    Aligos Therapeutics

    Healthy Volunteers

    phase 1 small molecule completed

    1 trial
  14. Atumelnant

    Crinetics Pharmaceuticals Europe GmbH

    Healthy Volunteers

    phase 1 small molecule active

    2 trials
  15. Azithromycin

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    1 trial
  16. Azithromycin 600 mg Tablet

    Teva Pharma GmbH

    Healthy

    phase 1 small molecule completed

    2 trials
  17. BBP-671

    BridgeBio Oncology Therapeutics

    Healthy Volunteers

    phase 1 small molecule terminated

    1 trial
  18. BBP-711

    BridgeBio Oncology Therapeutics

    Healthy

    phase 1 small molecule completed

    1 trial
  19. BDR17530

    Sanofi-aventis Healthcare Pty Ltd

    Healthy Volunteer

    phase 1 other active

    1 trial
  20. BEAM-103

    Beam Therapeutics

    Healthy Subjects

    phase 1 small molecule active

    1 trial
  21. BF-Amlodipine Tablet 10mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  22. BF-Gliclazide Tablet 80mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial
  23. BF-Lisinopril Tablets 20mg

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule active

    1 trial
  24. BF-Methyldopa 250mg Tablet

    BRIGHT MINDS BIOSCIENCES INC.

    Healthy

    phase 1 small molecule completed

    1 trial

Frequently asked questions

What is the Clinical Development Intelligence Platform?

It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.

How does this compare to Evaluate Pharma or Citeline?

Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.

Where does pipeline data come from?

Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.

Can I follow a company or program for updates?

Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.